![Philippe Moingeon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Philippe Moingeon
Plus aucun poste en cours
Profil
Philippe Moingeon served as Senior VP-Research & Pharmaceutical Development at Stallergenes SA from 2003 to 2012.
He holds an MBA from Harvard Medical School.
Anciens postes connus de Philippe Moingeon
Sociétés | Poste | Fin |
---|---|---|
STALLERGENES | Directeur Technique/Scientifique/R&D | - |
Formation de Philippe Moingeon
Harvard Medical School | Masters Business Admin |
Expériences
Fonctions occupées
Sociétés liées
Entreprise privées | 1 |
---|---|
Stallergenes SA
![]() Stallergenes SA Pharmaceuticals: MajorHealth Technology Stallergenes SA is an international biopharmaceutical company, which engages in the manufacture and sale of pharmaceutical products for the treatment of allergy-related respiratory diseases. The company operates through the Allergen Immunotherapy segment, which provides products and services for the desensitization of allergy-related respiratory conditions. Its products include a range of sublingual route and subcutaneous route products for the treatment of respiratory diseases such as rhino-conjunctivitis, rhinitis, and allergic asthma. Stallergenes was founded in 1962 and is headquartered in Antony, France. | Health Technology |